NCT03814954View on ClinicalTrials.gov

Nebulized Epinephrine vs. Salbutamol in Bronchiolitis Among Children

NACompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

January 1, 2019

Primary Completion Date

August 31, 2021

Study Completion Date

August 31, 2021

Conditions
Respiratory Distress Score
Interventions
DRUG

Salbutamol

At first day of admission, patients will receive 3 doses of nebulized salbutamol every 20 minutes. Then after 24 hours patients will receive standing dose according to clinical status

DRUG

Epinephrine

At first day of admission, patients will receive 3 doses of nebulized epinephrine every 20 minutes. Then after 24 hours patients will receive standing dose according to clinical status

Trial Locations (1)

Unknown

Makassed General Hospital, Beirut

All Listed Sponsors
lead

Makassed General Hospital

OTHER

NCT03814954 - Nebulized Epinephrine vs. Salbutamol in Bronchiolitis Among Children | Biotech Hunter | Biotech Hunter